Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -20.75% is 93% below its 5-year average of -10.72%, near the high end of its 5-year range (-114.73%–-0.65%).
As of the fiscal period ended Sunday, May 31, 2026. 19.42% below its 12-month average of -17.37%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-05-31): -20.75%.
RETURN ON INVESTED CAPITAL (ROIC)
-20.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-17.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-39.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-10.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-8.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-3.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-1.61%
CURRENT VS TTM AVG
-19.42%
CURRENT VS 3Y AVG
+47.36%
CURRENT VS 5Y AVG
-93.48%
CURRENT VS 10Y AVG
-140.90%
CURRENT VS 15Y AVG
-504.70%
CURRENT VS 20Y AVG
-1187.89%
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 666 covered companies
CURRENT VS SECTOR MEDIAN
+37.85%
vs the sector median at left
AngioDynamics, Inc.
Market Cap
$609.65M
Return on Invested Capital (ROIC)
-20.75%
TTM Avg
-17.37%
3Y Avg
-39.41%
5Y Avg
-10.72%
Market Cap
$601.66M
Return on Invested Capital (ROIC)
58.60%
TTM Avg
17.42%
3Y Avg
-47.16%
5Y Avg
-23.48%
Market Cap
$600.42M
Return on Invested Capital (ROIC)
-47.96%
TTM Avg
-47.20%
3Y Avg
-41.20%
5Y Avg
-37.18%
Market Cap
$593.29M
Return on Invested Capital (ROIC)
-11.80%
TTM Avg
-7.26%
3Y Avg
-5.22%
5Y Avg
9.70%
Market Cap
$621.32M
Return on Invested Capital (ROIC)
-90.42%
TTM Avg
-73.13%
3Y Avg
-82.56%
5Y Avg
-61.25%
Market Cap
$588.70M
Return on Invested Capital (ROIC)
-4.97%
TTM Avg
-6.49%
3Y Avg
-6.53%
5Y Avg
-6.86%
Market Cap
$640.40M
Return on Invested Capital (ROIC)
-26.94%
TTM Avg
-40.40%
3Y Avg
-38.31%
5Y Avg
-45.27%
Market Cap
$576.52M
Return on Invested Capital (ROIC)
-45.62%
TTM Avg
-46.61%
3Y Avg
-61.97%
5Y Avg
-71.18%
Market Cap
$645.84M
Return on Invested Capital (ROIC)
-42.02%
TTM Avg
-66.01%
3Y Avg
-48.82%
5Y Avg
-55.42%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AngioDynamics, Inc. (ANGO) | $609.65M | -20.75% | -17.37% | -39.41% | -10.72% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $601.66M | 58.60% | 17.42% | -47.16% | -23.48% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $600.42M | -47.96% | -47.20% | -41.20% | -37.18% |
| Fulgent Genetics, Inc. (FLGT)vs › | $593.29M | -11.80% | -7.26% | -5.22% | 9.70% |
| Prime Medicine, Inc. (PRME)vs › | $621.32M | -90.42% | -73.13% | -82.56% | -61.25% |
| OrthoPediatrics Corp. (KIDS)vs › | $588.70M | -4.97% | -6.49% | -6.53% | -6.86% |
| Climb Bio, Inc. (CLYM)vs › | $640.40M | -26.94% | -40.40% | -38.31% | -45.27% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $576.52M | -45.62% | -46.61% | -61.97% | -71.18% |
| Aura Biosciences, Inc. (AURA)vs › | $645.84M | -42.02% | -66.01% | -48.82% | -55.42% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $567.12M | -25.42% | 25.46% | -12.61% | -20.42% |
ROIC
-20.7%
ROE
-21.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-05-31 | -20.75% |
| 2026-02-28 | -13.01% |
| 2025-11-30 | -14.59% |
| 2025-08-31 | -18.97% |
| 2025-05-31 | -19.55% |
| 2025-02-28 | -22.88% |
| 2024-11-30 | -114.73% |
| 2024-08-31 | -108.49% |
| 2024-05-31 | -83.22% |
| 2024-02-29 | -82.63% |
| 2023-11-30 | -1.86% |
| 2023-08-31 | -0.65% |
| 2023-05-31 | -11.04% |
| 2023-02-28 | -7.61% |
| 2022-11-30 | -6.83% |
| 2022-08-31 | -6.85% |
| 2022-05-31 | -5.84% |
| 2022-02-28 | -8.84% |
| 2021-11-30 | -8.43% |
| 2021-08-31 | -7.60% |
| 2021-05-31 | -7.00% |
| 2021-02-28 | -32.01% |
| 2020-11-30 | -31.84% |
| 2020-08-31 | -31.51% |
| 2020-05-31 | -30.67% |
| 2020-02-29 | -3.94% |
| 2019-11-30 | -3.65% |
| 2019-08-31 | -3.65% |
| 2019-05-31 | -3.72% |
| 2019-02-28 | -1.07% |
| 2018-11-30 | 0.09% |
| 2018-08-31 | 0.65% |
| 2018-05-31 | 1.61% |
| 2018-02-28 | -0.80% |
| 2017-11-30 | -0.76% |
| 2017-08-31 | 0.81% |
| 2017-05-31 | 1.09% |
| 2017-02-28 | 1.67% |
| 2016-11-30 | 1.39% |
| 2016-08-31 | 0.16% |
| 2016-05-31 | -0.19% |
| 2016-02-29 | 0.57% |
| 2015-11-30 | -1.11% |
| 2015-08-31 | -0.55% |
| 2015-05-31 | -0.14% |
| 2015-02-28 | 0.09% |
| 2014-11-30 | 1.26% |
| 2014-08-31 | 1.04% |
| 2014-05-31 | 0.91% |
| 2014-02-28 | 1.42% |
| 2013-11-30 | 0.56% |
| 2013-08-31 | 1.04% |
| 2013-05-31 | 0.95% |
| 2013-02-28 | -0.13% |
| 2012-11-30 | -0.52% |
| 2012-08-31 | -0.74% |
| 2012-05-31 | -0.44% |
| 2012-02-29 | 0.41% |
| 2011-11-30 | 1.87% |
| 2011-08-31 | 2.08% |
| 2011-05-31 | 2.20% |
| 2011-02-28 | 3.33% |
| 2010-11-30 | 3.26% |
| 2010-08-31 | 3.26% |
| 2010-05-31 | 3.29% |
| 2010-02-28 | 3.07% |
| 2009-11-30 | 2.70% |
| 2009-08-31 | 2.72% |
| 2009-05-31 | 2.78% |
| 2009-02-28 | 2.06% |
| 2008-11-30 | 2.86% |
| 2008-08-31 | 2.79% |
| 2008-05-31 | 2.70% |
| 2008-02-29 | 3.34% |
| 2007-11-30 | -2.13% |
| 2007-08-31 | -2.66% |
| 2007-05-31 | -3.09% |
| 2006-02-25 | 10.05% |
| 2005-02-26 | 9.60% |
